References
- Vachon MG, Chulia D. The use of energy indices in estimating powder compaction functionality of mixtures in pharmaceutical tableting. Int J Pharm 1999;117:163–200.
- Joneja SK, Harcum WW, Skinner GW, Barnum PE, Guo JH. Investigating the fundamental effects of binders on Pharmaceutical Tablets Performance. Drug Dev Ind Pharm 1999;25(10):1129–1135.
- Brunauer S, Emmett PH, Teller E. Absorption of gases in multimolecular layers. J Am Chem Soc 1938;60:309.
- Briggner L-E, Buckton G, Bystrom K, Darcy P. The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders. Int J Pharm 1994;105:125–135.
- Brodka-Pfeiffer K, Langguth P, Grass P, Hausler H., Influence of mechanical activation on the physical stability of salbutamol sulphate. Eur J Pharm Biopharm 2003;56:393–400.
- Feeley JC, York P, Sumby BS, Dicks H. Determination of surface properties and flow characteristics of salbutamol sulphate, before and after micronization. Int J Pharm 1998;172:89–96.
- Feeley JC, York P, Sumby BS, Dicks H. Processing effects on the surface properties of alpha-lactose monohydrate assesses by inverse gas chromatography (IGC). J Mater Sci 2002;37:217–222.
- Zhou D, Zhang GGZ, Law D, Grant DJW, Schmitt EA. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility. J Pharm Sci 2002;19(8):1863–1872.
- Hancock BC, Carlson GT, Ladipo DD, Langdon BA, Mullarney MP. Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance. Int J Pharm 2002;241:73–85.
- Fix I, Steffens KJ. Quantifying low amorphous or crystalline amounts of alpha-lactose-monohydrate using X-ray powder diffraction, near-infrared spectroscopy, and differential scanning calorimetry. Drug Dev Ind Pharm 2004;30(5):513–523.
- Byard SJ, Jackson SL, Smail A, Bauer M, Apperley DC. Studies on the crystallinity of a pharmaceutical development drug substance. J Pharm Sci 2005;94:1321–1335.
- Sebbatu T, Angberg M, Ahlneck C. Assessment of degree of disorder in crystalline solids by isothermal microcalorimetry. Int J Pharm 1994;104:135–144.
- Giron D, Remy P, Thomas S, Vilette E. Quantitation of amorphicity by microcalorimetry. J Therm Anal 1997;48:465–472.
- Venkatesh GM, Barnett ME, Owusu-Fordjour C, Galop M. Detection of low levels of the amorphous phase in crystalline pharmaceutical materials by thermally stimulated current spectrometry. Pharm Res 2001;18:98–103.
- Taylor LS, Zografi G. The quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharm Res 1998;15:755–761.
- Bertacche V, Pini E, Stradi R, Stratta F. Quantitative determination of amorphous cyclosporine in crystalline cyclosporine samples by Fourier transform infrared spectroscopy. J Pharm Sci 2006;95:159–166.
- Hogan SE, Buckton G. The application of near infrared spectroscopy and dynamic vapor sorption to quantify low amorphous contents of crystalline lactose. Pharm Res 2001;18:112–116.
- Saleki-Gerhardt A, Ahlneck C, Zografi G. Assessment of disorder in crystalline solids. Int J Pharm 1994;101:237–247.
- Carvajal MT, Staniforth JN. Interactions of water with the surfaces of crystal polymorphs. Int J Pharm 2006;307:216–224.
- Mackin L, Sartnurak S, Thomas I, Moore S. The impact of low levels of amorphous material (< 5%) on the blending characteristics of a direct compression formulation. Int J Pharm 2002;231:213–226.
- Mackin L, Zanon R, Park JM, Foster K, Opalenik H, Demonte M. Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapor sorption and isothermal microcalorimetry. Int J Pharm 2002;231:227–236.